Jacobson Pharma Corporation Limited Stock price

Equities

2633

KYG677291067

Pharmaceuticals

Delayed Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
0.59 HKD +1.72% Intraday chart for Jacobson Pharma Corporation Limited -1.67% -7.81%
Sales 2022 1.6B 204M Sales 2023 1.79B 228M Capitalization 1.85B 236M
Net income 2022 178M 22.75M Net income 2023 251M 32.07M EV / Sales 2022 1.33 x
Net Debt 2022 880M 112M Net Debt 2023 511M 65.24M EV / Sales 2023 1.32 x
P/E ratio 2022
7.01 x
P/E ratio 2023
7.39 x
Employees 1,588
Yield 2022
5.97%
Yield 2023
5.34%
Free-Float 20.34%
More Fundamentals * Assessed data
Dynamic Chart
Jacobson Pharma Raises HK$39 Million from Share Placement MT
Jacobson Pharma Reports 42% Fiscal H1 Profit Growth; Shares Rise MT
Jacobson Pharma Corporation Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Jacobson Pharma Corporation Limited Announces Interim Dividend for the Six Months Ended September 30, 2023, Payable on 10 January 2024 CI
JBM (Healthcare), Jacobson Pharma Shares Rise on M&A Deal MT
Jacobson Pharma Corporation Declares A Final Dividend for the Year Ended 31 March 2023 CI
Jacobson Pharma's Dividend Shrinks Despite Surge in FY23 Net Profit MT
Jacobson Pharma Corporation Limited Proposes Final Dividend for the Year Ended 31 March 2023, Payable on 1 September 2023 CI
Jacobson Pharma Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Jacobson Pharma Forecasts 40% Growth in FY23 Profit MT
Jacobson Pharma Corporation Limited Provides Earning Guidance for the Year Ended 31 March 2023 CI
Jacobson Pharma Boosts Interim Dividend as April-September Profit Increases MT
Jacobson Pharma Corporation Limited Announces Interim Dividend for the Six Months Ended 30 September 2022, Payable on 29 December 2022 CI
Jacobson Pharma Corporation Limited Reports Earnings Results for the Half Year Ended September 30, 2022 CI
Jacobson Pharma Expects Up to 70% Rise in April-September Profit; Shares Rise 4% MT
More news
1 day+1.72%
1 week-1.67%
Current month-1.67%
1 month-6.35%
3 months-7.81%
6 months-9.23%
Current year-7.81%
More quotes
1 week
0.56
Extreme 0.56
0.60
1 month
0.56
Extreme 0.56
0.62
Current year
0.54
Extreme 0.54
0.64
1 year
0.54
Extreme 0.54
1.08
3 years
0.44
Extreme 0.435
1.11
5 years
0.44
Extreme 0.435
1.87
10 years
0.44
Extreme 0.435
2.28
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 16-02-15
Director of Finance/CFO 52 18-12-31
Director/Board Member 72 -
Members of the board TitleAgeSince
Director/Board Member 62 16-03-31
Director/Board Member 65 16-04-10
Director/Board Member 60 16-08-29
More insiders
Date Price Change Volume
24-03-28 0.59 +1.72% 48,000
24-03-27 0.58 -1.69% 306,000
24-03-26 0.59 0.00% 482,000
24-03-25 0.59 -3.28% 68,000
24-03-22 0.61 +1.67% 10,000

Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT

More quotes
Jacobson Pharma Corporation Ltd is an investment holding company principally engaged in the manufacturing and sale of generic drugs. The Company operates its business through two segments. The Generic Drugs segment is engaged in the development, manufacture and distribution of a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment is engaged in the development, manufactures and distributes branded medicines, proprietary Chinese medicines and health and wellness products. Currently the activities of two segments in this regard are primarily carried out in Hong Kong.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Jacobson Pharma Corporation Limited - Hong Kong S.E.